NEW BRUNSWICK, N.J.,
Oct. 28, 2016 /PRNewswire/
-- Susan Lee Lindquist, Ph.D., member of the Johnson &
Johnson (NYSE: JNJ) board of directors and world-renowned
biomedical innovator, today lost her battle with cancer.
An insightful leader with an incomparable perspective on the
intersection of academic and medical research, Dr. Lindquist served
as an elected member of the Johnson & Johnson board of
directors since 2004, chairing its Science, Technology &
Sustainability Committee and sitting on its Regulatory, Compliance
& Government Affairs Committee.
"Dr. Lindquist's impact in the field of biomedical innovation,
as well as her entrepreneurial spirit, courageous leadership and
commitment to teaching, is an inspiration for all of us and for
generations to come," said Alex
Gorsky, Chairman and Chief Executive Officer of Johnson
& Johnson. "She has made invaluable contributions to Johnson
& Johnson, consistently challenging us to deliver more
innovation, enhance our commitment to scientific excellence, and
remain focused on meeting the needs of patients worldwide."
Dr. Lindquist was a widely respected researcher with a global
reputation as a pioneer in biomedical innovation. During her nearly
40-year career, she not only made numerous, instrumental
contributions to the study of protein folding, but also was a
committed teacher and mentor. As a biomedical entrepreneur, she
co-founded FoldRx Pharmaceuticals and founded Yumanity Therapeutics
and REVOLUTION Medicines. She received many awards and honors
recognizing her groundbreaking work.
Dr. Lindquist earned an undergraduate degree in microbiology
from the University of Illinois at
Urbana-Champaign and a Ph.D. in biology from Harvard University.
"On behalf of the board of directors and the employees of
Johnson & Johnson, we extend our deepest sympathies to Dr.
Lindquist's family and friends, and the many colleagues and
patients whose lives she touched. She will be missed," said
Gorsky.
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the
people of Johnson & Johnson. We embrace research and science -
bringing innovative ideas, products and services to advance the
health and well-being of people. Our approximately 126,900
employees at more than 250 Johnson & Johnson operating
companies work with partners in health care to touch the lives of
over a billion people every day, throughout the world.
Logo - http://photos.prnewswire.com/prnh/20160831/403394LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/johnson--johnson-mourns-the-loss-of-susan-lindquist-biomedical-research-pioneer-and-member-of-the-johnson--johnson-board-of-directors-300353677.html
SOURCE Johnson & Johnson